Last reviewed · How we verify
Inflammatory Disease of Female Pelvic Organs
Approved treatments
- Cleocin T · Pfizer
Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death. - Unasyn · Bristol-Myers Squibb
- Cleocin · Generic (originally Upjohn/Pfizer)
Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage. - Abelcet · Astellas Pharma
- Unasyn · Pfizer
- Pipracil
Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death. - Ceftriaxon · Centre Hospitalier Universitaire Vaudois
- Azactam · Bristol-Myers Squibb
Aztreonam inhibits bacterial cell wall synthesis, acting as a bactericidal agent. - Primaxin · Merck Sharp & Dohme B.V.
Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Fortaz · Pai Holdings Pharm
Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death. - Mefoxin In Sodium Chloride 0.9% In Plastic Container
- Cefotan
- Primaxin · Merck & Co.
Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body. - TICARCILLIN
- Ticarcillin
- Fortaz · Pai Holdings Pharm
Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance. - Zosyn · Merck Sharp & Dohme B.V.
Zosyn works by blocking bacterial enzymes that break down antibiotics, allowing the antibiotics to kill bacteria more effectively. - Rocephin · Generic (originally Roche)
- Ceftazidim · Tel-Aviv Sourasky Medical Center
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Inflammatory Disease of Female Pelvic Organs patent landscape — cliff calendar, originator estates, attackable patents
- Inflammatory Disease of Female Pelvic Organs treatment landscape brief
- Inflammatory Disease of Female Pelvic Organs treatment updates RSS
Frequently asked questions about Inflammatory Disease of Female Pelvic Organs
What drugs treat Inflammatory Disease of Female Pelvic Organs?
Tracked treatments include Cleocin T, Unasyn, Cleocin, Abelcet, Pipracil, Ceftriaxon, Azactam, Primaxin.
What is the treatment for Inflammatory Disease of Female Pelvic Organs?
Standard treatment for Inflammatory Disease of Female Pelvic Organs includes Cleocin T, Unasyn, Cleocin, Abelcet, Pipracil. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Inflammatory Disease of Female Pelvic Organs patent cliff · Inflammatory Disease of Female Pelvic Organs CI report
- Treatment: Cleocin T · Pfizer
- Treatment: Unasyn · Bristol-Myers Squibb
- Treatment: Cleocin · Generic (originally Upjohn/Pfizer)
- Treatment: Abelcet · Astellas Pharma
- Treatment: Unasyn · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing